Loading institutional data...
Loading institutional data...
Institutional distribution: ownership decreased -0.52% quarter-over-quarter.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Ownership trend chart requires at least 2 quarters of data.
More quarterly data is being processed.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $0.71 today, the market must believe free cash flow compounds 34.3%/yr for a decade (off $88937 normalized FCF).
The market's 34.3% is more optimistic than its 9-yr track record.
2-stage DCF · 0.02B shares · net debt $1M
mean -70.2% · volatility σ 185% · implied rate exceeded in 1/4 yrs
Central path = implied 34.3%/yr growth; shaded band = ±1σ (185%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on $88937 FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: -13%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $345112 is below the $1M due within a year — relies on refinancing or operating cash flow. Scheduled principal only (excludes interest & revolver draws). As of 2017-06-30 (10-Q).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~1.9% on $1M of debt.
Cash of $345112 is below short-term debt of $1M — relies on refinancing/operations.
Mostly short-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Top 6 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 1085 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BCAX | $1.20T | — | — | — | — | — | — | -34.4% | -34.4% | — | 143 |
| LLY | $1.02T | 49.6× | — | 15.7× | 44.7% | 83.0% | 31.7% | 77.8% | 29.9% | — | 4,193 |
| AKTX | $916.2B | — | — | — | — | — | — | -61.1% | -61.1% | — | 1 |
| JNJ | $643.4B | 24.2× | — | 6.8× | 6.0% | 67.9% | 28.5% | 32.9% | 20.7% | — | 4,451 |
| ABBV | $464.4B | 111.2× | 33.2× | 7.6× | 8.6% | 70.2% | 6.9% | -129% | 6.6% | 4.2× | 3,895 |
| MRK | $362.6B | 19.9× | — | 5.6× | 1.3% | 74.8% | 28.1% | 34.7% | 17.9% | — | 3,594 |
| UNH | $340.0B | 28.4× | 19.7× | 0.8× | 11.8% | 88.7% | 2.7% | 12.0% | 6.8% | 3.9× | 2,891 |
| AZN | $252.6B | — | — | — | — | — | — | — | — | — | 1,248 |
| TMO | $244.5B | 36.5× | 31.5× | 5.5× | 3.9% | — | 15.0% | 12.6% | 7.0% | 4.9× | 2,481 |
| AMGN | $202.8B | 26.4× | 17.4× | 5.5× | 10.0% | 67.2% | 21.0% | 89.1% | 12.2% | 3.8× | 3,014 |
| GILD | $183.3B | 21.8× | 20.0× | 6.2× | 2.4% | 78.8% | 28.9% | 37.5% | 17.9% | 2.4× | 2,218 |
| ABT | $178.2B | 27.5× | 19.3× | 4.0× | 5.7% | 56.4% | 14.7% | 12.5% | 10.0% | 1.4× | 2,964 |
| PFE | $156.1B | 20.2× | — | 2.5× | -1.6% | 74.3% | 12.4% | 9.0% | 5.1% | — | 2,838 |
| DHR | $147.3B | 41.3× | 30.5× | 6.0× | 2.9% | 59.1% | 14.7% | 6.9% | 5.1% | 3.4× | 2,083 |
| ISRG | $135.8B | 48.6× | 37.3× | 13.5× | 20.5% | 66.0% | 28.4% | 16.0% | 16.0% | — | 2,190 |
| VRTX | $130.4B | 33.5× | 28.6× | 10.9× | 8.9% | 86.2% | 32.9% | 21.2% | 21.2% | — | 1,609 |
| BMY | $129.4B | 18.4× | — | 2.7× | -0.2% | 71.1% | 14.6% | 38.2% | 11.1% | — | 2,431 |
| MDT | $118.5B | 24.8× | 12.6× | 3.3× | 8.4% | 65.0% | 13.2% | 9.7% | 9.4% | 0.2× | 2,114 |
| LGVN | $117.4B | — | — | 97924.4× | -49.9% | 67.0% | -1894% | -400% | -400% | — | 31 |
| CVS | $116.6B | 66.0× | 11.7× | 0.3× | 7.8% | 45.0% | 0.4% | 2.4% | 2.4% | 0.0× | 1,795 |
| SYK | $108.8B | 33.9× | 18.7× | 4.3× | 11.2% | 64.0% | 12.9% | 14.5% | 8.5% | 2.5× | 2,196 |
| MCK | $103.4B | 23.1× | 16.3× | 0.3× | 12.4% | 3.6% | 1.2% | -219% | 109% | 1.0× | 1,946 |
| HCA | $96.7B | 15.2× | — | 1.3× | 7.1% | — | 9.0% | -113% | 16.8% | — | 1,346 |
| ELV | $91.1B | 16.4× | 15.4× | 0.5× | 12.5% | 89.4% | 2.8% | 12.9% | 7.6% | 4.2× | 1,397 |
| REGN | $81.0B | 18.7× | 19.4× | 5.7× | 1.0% | — | 31.4% | 14.4% | 13.6% | 0.5× | 1,336 |
| CPHI | $11M | — | — | 2.7× | -8.5% | -3.2% | -76.9% | -14.0% | -13.2% | -0.8× | 6 |
Peers = companies sharing CPHI's sector (Healthcare) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.1M 100.0% | $4.5M 100.0% | $7.0M 100.0% | $8.1M 100.0% | $9.6M 100.0% | $10.9M 100.0% | $10.9M 100.0% | $12.3M 100.0% | $13.2M 100.0% | $15.6M 100.0% |
| Cost of Revenue | $4.3M 103.2% | $6.5M 143.8% | $7.3M 104.0% | $8.6M 106.1% | $9.3M 96.4% | $8.9M 82.0% | $9.4M 86.4% | $10.4M 84.0% | $10.7M 81.3% | $12.4M 79.3% |
| Gross Profit | -$132K -3.2% | -$2.0M -43.8% | -$281K -4.0% | -$494K -6.1% | $349K 3.6% | $2.0M 18.0% | $1.5M 13.6% | $2.0M 16.0% | $2.5M 18.7% | $3.2M 20.7% |
| Research & Development | $281K 6.8% | $284K 6.3% | $240K 3.4% | $186K 2.3% | $319K 3.3% | $378K 3.5% | $230K 2.1% | $172K 1.4% | $90K 0.7% | $366K 2.4% |
| Selling, General & Admin | $2.5M 59.2% | $1.8M 39.4% | $1.5M 20.9% | $1.9M 23.4% | $1.7M 17.1% | $1.8M 16.8% | $2.3M 21.0% | $1.9M 15.8% | $2.0M 15.3% | $2.3M 14.6% |
| Total Operating Expenses | $3.1M 75.0% | $2.6M 57.5% | $2.5M 35.2% | $3.1M 37.7% | $3.2M 33.3% | $4.5M 41.7% | $21.9M 200.4% | $12.4M 100.7% | $21.1M 160.1% | $11.7M 75.3% |
| Operating Income | -$3.2M -78.2% | -$4.6M -101.3% | -$2.8M -39.2% | -$3.5M -43.8% | -$2.9M -29.7% | -$2.6M -23.7% | -$20.4M -186.8% | -$10.4M -84.7% | -$18.7M -141.4% | -$8.2M -52.4% |
| Interest Expense | $27K 0.7% | $27K 0.6% | $31K 0.4% | $435K 5.4% | $542K 5.6% | $294K 2.7% | $322K 2.9% | $451K 3.7% | $539K 4.1% | $850K 5.5% |
| Interest & Investment Income | $2K 0.0% | $7K 0.1% | $7K 0.1% | $11K 0.1% | $3K 0.0% | $6K 0.1% | $28K 0.3% | $39K 0.3% | $64K 0.5% | $131K 0.8% |
| Other Income (Expense), net | $52K 1.2% | -$147K -3.3% | -$327K -4.7% | -$424K -5.2% | -$539K -5.6% | -$288K -2.7% | -$294K -2.7% | -$413K -3.3% | -$475K -3.6% | -$719K -4.6% |
| Pretax Income | -$3.2M -76.9% | -$4.7M -104.6% | -$3.1M -43.9% | -$4.0M -49.0% | -$3.4M -35.3% | -$2.9M -26.4% | -$20.7M -189.5% | -$10.9M -88.1% | -$19.2M -145.0% | -$8.9M -57.0% |
| Income Tax Expense | — | — | — | — | — | — | — | -$110K -0.9% | $123K 0.9% | $308K 2.0% |
| Net Income | -$3.2M -76.9% | -$4.7M -104.6% | -$3.1M -43.9% | -$4.0M -49.0% | -$3.4M -35.3% | -$2.9M -26.4% | -$20.7M -189.5% | -$10.8M -87.2% | -$19.3M -145.9% | -$9.2M -59.0% |
| Per Share | ||||||||||
| EPS (Basic) | $-0.74 | $-2.71 | $-0.91 | $-3.78 | $-0.74 | — | — | — | — | — |
| EPS (Diluted) | $-0.74 | $-2.71 | $-0.91 | $-3.78 | $-0.74 | — | — | — | — | — |
| Weighted Avg Shares (Basic) | 4.3M | 1.7M | 3.4M | 1.1M | 4.6M | — | — | — | — | — |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
EOD close · as of 2026-09-17
No standout strengths flagged.
Where each multiple sits in its own 14-yr range · 4th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 3.5× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 84.0 | 86.4 | 82.0 | 96.4 | 106.1 | 104.0 | 143.8 | 103.2 |
| Gross Profit | 16.0 | 13.6 | 18.0 | 3.6 | -6.1 | -4.0 | -43.8 | -3.2 |
| R&D | 1.4 | 2.1 | 3.5 | 3.3 | 2.3 | 3.4 | 6.3 | 6.8 |
| SG&A | 15.8 | 21.0 | 16.8 | 17.1 | 23.4 | 20.9 | 39.4 | 59.2 |
| Operating Income | -84.7 | -186.8 | -23.7 | -29.7 | -43.8 | -39.2 | -101.3 | -78.2 |
| Income Tax | -0.9 | — | — | — | — | — | — | — |
| Net Income | -87.2 | -189.5 | -26.4 | -35.3 | -49.0 | -43.9 | -104.6 | -76.9 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on CPHI: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.